Viking Therapeutics Files Q1 2026 10-Q Report
Ticker: VKTX · Form: 10-Q · Filed: Apr 30, 2026 · CIK: 0001607678
| Field | Detail |
|---|---|
| Company | Viking Therapeutics, Inc. (VKTX) |
| Form Type | 10-Q |
| Filed Date | Apr 30, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
TL;DR
Viking Therapeutics filed its Q1 2026 10-Q. Check financials.
AI Summary
Viking Therapeutics, Inc. filed its quarterly report on Form 10-Q for the period ending March 31, 2026. The filing includes financial statements and other disclosures relevant to investors. The company's mailing and business address is 9920 Pacific Heights Blvd, Suite 350, San Diego, CA 92121.
Why It Matters
This 10-Q filing provides investors with an updated view of Viking Therapeutics' financial health and operational status as of March 31, 2026.
Risk Assessment
Risk Level: low — This filing is a standard quarterly report and does not contain inherently high-risk information.
Key Numbers
- 2026-03-31 — Period End Date (Indicates the financial reporting period covered by the 10-Q.)
- 2026-04-30 — Filing Date (The date Viking Therapeutics submitted this quarterly report.)
Key Players & Entities
- Viking Therapeutics, Inc. (company) — Filer of the 10-Q report
- 0001607678 (company) — CIK number for Viking Therapeutics, Inc.
- 2026-03-31 (date) — Period of report for the 10-Q
- 2026-04-30 (date) — Filing date of the 10-Q
- 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 (address) — Mailing and Business Address for Viking Therapeutics, Inc.
FAQ
What is the CIK number for Viking Therapeutics, Inc.?
The CIK number for Viking Therapeutics, Inc. is 0001607678.
What is the period of report for this 10-Q filing?
The period of report for this 10-Q filing is March 31, 2026.
When was this 10-Q filing accepted by the SEC?
This 10-Q filing was accepted on April 29, 2026.
What is the business address of Viking Therapeutics, Inc.?
The business address of Viking Therapeutics, Inc. is 9920 Pacific Heights Blvd, Suite 350, San Diego, CA 92121.
What is the SIC code listed for Viking Therapeutics, Inc.?
The SIC code listed for Viking Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on April 30, 2026 regarding Viking Therapeutics, Inc. (VKTX).